| Patent # | Description |
|---|---|
| US-5,580,897 |
1,2-dithiins having antifungal activity Novel 1,2-dithiin compounds useful as antifungal or anti-infective agents, as well as methods for their use as such, are described. The 1,2-dithiin compounds are... |
| US-5,580,896 |
Treatment of pain and colorectal cancer with dipeptoids of
.alpha.-substituted Trp-Phe derivatives This invention relates to the treatment of pain and inhibiting the growth of colorectal cancer with dipeptoids of .alpha.-substituted Trp-Phe derivatives. |
| US-5,580,895 |
1,5-benzodiazepine derivatives The present invention relates to compounds of formula (I) which are antagonists of gastrin and CCK-B receptors. The compounds of formula (I) are... |
| US-5,580,894 |
Isoxazolyl enaminones An oxazolyl enaminone is provided having the formula: ##STR1## wherein R.sub.1 is selected from the group consisting of a branched or unbranched alkyl... |
| US-5,580,893 |
Nitroxyalkylamide derivatives Nitroxyalkylamide compounds having the formula: R.sup.1 --(A).sub.n --CONH--B'--ONO.sub.2 wherein R.sup.1 is an optionally substituted furyl, furyloxy, thienyl,... |
| US-5,580,892 |
Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents A pharmaceutical composition, useful for treating animals of the mammalian species, including humans, to treat diseases and conditions which normally respond to... |
| US-5,580,891 |
N-[heteroaryl-1-pyrrolidinyl)alkyl]-2-benoxazolinones and related
compounds and their therapeutic utility Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. the compounds are especially useful for treating psychoses... |
| US-5,580,890 |
Heteroarylpyrrolidines and their use as antipsychotics and analgesics Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. the compounds are especially useful for treating psychoses... |
| US-5,580,889 |
Insecticidal nitromethyl or niteoimino-heteromethyl-heterocyclics Novel insecticides of the formula ##STR1## in which n is 0 or 1, X is S, O, ##STR2## Y is N or ##STR3## Z is a 5- or 6-membered... |
| US-5,580,888 |
Styryl derivatives as anti-inflammatory agents Compounds of general formula (1) ##STR1## are described wherein Y is a halogen atom or a group --OR.sup.1, wherein R.sup.1 is an optionally substituted... |
| US-5,580,887 |
1- (arylthioalkyl , arylaminoalkyl or arylmethylenealkyl) -4-
(heteroaryl) piperidines and related compounds... Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. the compounds are especially useful for treating psychoses... |
| US-5,580,886 |
Cis-2-[(4-heteroaryl-1
-piperidinyl)alkyl]hexahydro-1H-isoindole-1,3(2H)-diones and related
compounds and... Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. The compounds are especially useful for treating psychoses... |
| US-5,580,885 |
5-HT.sub.4 receptor antagonists The use of a compound of formula (I) or pharmaceutically acceptable salt thereof, in which X.sub.1 --(CH.sub.2).sub.x --X.sub.2 forms a 5-7 membered ring... |
| US-5,580,884 |
Deoxygalactonojirimycin derivatives Novel N-alkyl derivatives of deoxygalactonojirimycin are provided in which said alkyl contains from 3-6 carbon atoms. These novel compounds are useful for... |
| US-5,580,883 |
Aminobenzene compounds to prevent nerve cell degradation A compound useful for central antioxidant having inhibitory activity of degeneration and necrocytosis of cerebral cells of the formula (I): ##STR1## wherein... |
| US-5,580,882 |
Use of substituted quinoline carboxamide The use of an anti-MS quinoline-3-carboxamide compound comprising the structure of formula (I), optionally with substituents for the H.sup.1-9 hydrogen, or a... |
| US-5,580,881 |
1,2,3,5,6,7,8,8a-Octahydro-5,5,8a-trimethyl-
(8a.beta.)-6-isoquinolineamine derivatives, preparation method... 1,2,3,5,6,7,8,8a-Octahydro-5,5,8a-trimethyl-(8a.beta.)-isoquinolineamines of formula (I), wherein groups R.sup.1 -R.sup.3 are as defined in the description, a... |
| US-5,580,880 |
Method for the treatment of xerostomia A method for the treatment of xerostomia not caused by Sjogren's syndrome comprising administering to an affected individual an effective amount of a derivative... |
| US-5,580,879 |
N-[(4-heteroaryl-1-pyrrolidinyl)alkyl]-1H-benz[DE]isoquinoline-1;3(2H)-di
ones and related compounds and their... Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. the compounds are especially useful for treating psychoses... |
| US-5,580,878 |
Substituted tryptamines phenalkylamines and related compounds This invention relates to novel substituted tryptamine and phenalkylamine and related compounds, pharmaceutical compositions thereof and methods of using said... |
| US-5,580,877 |
Pyrazolo-quinoline derivatives for treating cerebral ischemia A class of 3,5-dihydro-1H-pyrazolo[3,4-c]quinoline-1,4(2H)-dione derivatives, substituted in the 2-position by an optionally substituted phenyl moiety, are... |
| US-5,580,876 |
Method of simultaneously enhancing analgesic potency and attenuating
dependence liability caused by morphine... This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously... |
| US-5,580,875 |
1-[(2-pyrimidinyloxy)alkyl]-3-(heteroaryl)pyrrolidines and related
compounds and therapeutic utility Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents the compounds are especially useful for treating psychoses... |
| US-5,580,874 |
Enatiomerically pure hydroxylated xanthine compounds Them is disclosed compounds and pharmaceutical compositions that is R enantiomer of an .omega.-1 alcohol of a straight chain alkyl (C.sub.5-8) substituted at the... |
| US-5,580,873 |
Enatiomerically pure hydroxylated xanthine compounds to treat
proliferative vascular diseases There is disclosed compounds and pharmaceutical compositions that are a resolved R or S (preferably R) enantiomer of an .omega.-1 alcohol of a straight chain... |
| US-5,580,872 |
Quinolizinone type compounds Antibacterial compounds having the formula ##STR1## and the pharmaceutically acceptable salts, esters and amides thereof, preferred examples of which... |
| US-5,580,871 |
4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist and
alpha.sub.1 -antagonist activity There are provided novel 1,4-dihydropyridine compounds, compositions containing them and methods of using them to treat congestive heart failure. |
| US-5,580,870 |
Quinazoline derivatives The invention concerns quinazoline derivatives of the formula I ##STR1## wherein m is 1, 2 or 3 and each R.sup.1 includes hydroxy, amino, ureido, ... |
| US-5,580,869 |
1N substituted pyrazino[2,3-c]-1,2,6-thiadiazine 2,2-dioxides 1N substituted pyrazino[2,3-c]-1,2,6-thiadiazine 2,2-dioxides of formula I ##STR1## where: R.sub.1 and R.sub.2, which may be the same or different, are ... |
| US-5,580,868 |
Pyridyloxy-acrylic acid esters Novel pyridyloxy-acrylic acid esters of the formula ##STR1## in which Ar represents optionally substituted aryl or represents optionally substituted... |
| US-5,580,867 |
Myocardial protection during ischemia and reperfusion Myocardial protection is achieved by administering to a patient an effective amount of a benzothiazepine derivative. The benzothiazepine derivatives have the... |
| US-5,580,866 |
Therapeutic 1,4-thiazepines Compounds of formula I ##STR1## in which n=0, 1 or 2; R.sub.1, R.sub.2, R.sub.6 and R.sub.7 independently represent H or alkyl (optionally substituted by... |
| US-5,580,865 |
2,2-disubstituted cephem sulphones The present invention provides cephalosporin sulphones or formula (I), and pharmaceutically or veterinarily acceptable salts thereof; ##STR1## wherein n is... |
| US-5,580,864 |
Method of controlling male fertility A method of controlling male fertility in warm-blooded male animals comprising administering to male warm-blooded animals an amount of a compound selected from... |
| US-5,580,863 |
Benzopyran derivatives and their use This invention relates to a compound represented by the formula: ##STR1## wherein B represents a hydrogen atom or a lower alkyl group; ring A represents a... |
| US-5,580,862 |
Sulfate ligands for L-selectins and methods of preventing sulfate
addition Sulfated oligosaccharides which bind to selectin receptors and act as agonists are formulated into pharmaceutical formulations and administered by injection to... |
| US-5,580,860 |
Pharmaceutical composition containing
2-amino-6-chloropurine-9-.beta.-D-2',3'-dideoxyribofuranoxside An anti-AIDS virus agent is disclosed, which is characterized in that it contains the 2',3'-dideoxypurinenucleosides represented by the chemical formula (I): ... |
| US-5,580,859 |
Delivery of exogenous DNA sequences in a mammal Polynucleotide sequences, comprising DNA and RNA molecules can be directly administered, for example by injection, to tissues, such as muscle, and expressed as a... |
| US-5,580,858 |
Immunosuppressive and tolerogenic modified Lewis.sup.x compounds Disclosed are novel Lewis.sup.x and Lewis.sup.a analogues, pharmaceutical compositions containing such analogues, methods for their preparation and methods for... |
| US-5,580,857 |
Use of gibberellins for the treatment of prostatitis The use of active gibberellins for the preparation of a pharmaceutical composition for the treatment of prostatitis. The method results in a decrease in prostate... |
| US-5,580,856 |
Formulation of a reconstituted protein, and method and kit for the
production thereof Dried proteins are stabilized against loss of biological activity in formulations by adding an reconstitution stabilizer upon rehydration of the dried protein. A... |
| US-5,580,855 |
Peptides Peptides, the C-terminal amides thereof and the pharmaceutically acceptable salts of the said peptides and amides are useful in the prevention and treatment of... |
| US-5,580,854 |
Substrate-related peptidyl-aldehyde inhibitors of the proteolytic
activity of the multicatalytic proteinase complex The present invention provides novel peptidylaldehyde inhibitors of proteolysis mediated by the multicatalytic proteinase complex (MPC) or proteasome. The... |
| US-5,580,853 |
Modified polypeptides with increased biological activity Modified polypeptides with increased biological activity exhibited as either increased potency or prolonged circulating half-life are disclosed with methods of... |
| US-5,580,852 |
Derivatives of tachyplesin having inhibitory activity towards plant
pathogenic fungi Certain specific derivatives of the 17-amino acid peptide tachyplesin has been found to have antimicrobial activity against plant pathogens. In a preferred... |
| US-5,580,851 |
Solid consumer product compositions containing small particle
cyclodextrin complexes An effective amount of active/cyclodextrin complex, in the form of particles having particle sizes below about 12 microns, is incorporated into solid consumer... |
| US-5,580,850 |
Foaming detergent mixtures Described are detergent mixtures containing (a) quaternarized fatty-acid alkanolamine esters of formula (I), in which R.sup.1 CO is an aliphatic acyl group with... |
| US-5,580,849 |
Liquid or gel detergent compositions containing calcium and stabilizing
agent thereof Liquid or gel detergent compositions having improved physical stability comprise, by weight of the composition: (a) from about 3% to about 95% of anionic sulfate... |
| US-5,580,848 |
Microemulsion light duty liquid cleaning comnpositions A microemulsion light duty liquid detergent with desirable cleansing properties and mildness to the human skin comprising four essential surfactants: a water... |
| US-5,580,847 |
Aqueous ammonia composition An aqueous ammonia composition having low surface tension is disclosed, which comprises ammonia water and a fluoroalkylsulfonamide compound having the following... |